Celltrion
068270.KS
#881
Rank
HK$218.95 B
Marketcap
HK$954.78
Share price
3.14%
Change (1 day)
-5.47%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2026 (TTM): HK$19.73

According to Celltrion 's latest financial reports the company's current EPS (TTM) is HK$19.82. In 2025 the company made an earnings per share (EPS) of HK$24.24 an increase over its 2024 EPS that were of HK$9.20.

EPS history for Celltrion from 2007 to 2026

Annual EPS

Year EPS Change
2026 (TTM)HK$19.73-18.6%
2025HK$24.24163.66%
2024HK$9.20-53.73%
2023HK$19.87-2.08%
2022HK$20.30-11.72%
2021HK$22.992.03%
2020HK$22.5382.8%
2019HK$12.3318.31%
2018HK$10.42-36.33%
2017HK$16.36161.25%
2016HK$6.262.86%
2015HK$6.0917.84%
2014HK$5.175.87%
2013HK$4.88-70.85%
2012HK$16.74134.09%
2011HK$7.1543.59%
2010HK$4.9874.49%
2009HK$2.85317.8%
2008HK$0.68-71.7%
2007HK$2.41